Status | Study |
RECRUITING |
Study Name: A Study to Assess the Long-term Safety and Efficacy of a Subcutaneous Formulation of Efgartigimod in Adults With Active Idiopathic Inflammatory Myopathy Condition: Myositis Date: 2023-07-28 Interventions: Subcutaneous injection of efgartigimod coformulated with rHuPH20, a permeation enhancer |
RECRUITING |
Study Name: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Condition: Date: 2023-04-27 Interventions: anti-interferon beta therapy |
RECRUITING |
Study Name: A Study to Understand How the Study Medicine (PF-06823859) Works in People With Active Idiopathic Inflammatory Myopathies [Dermatomyositis (DM) and Polymyositis (PM)] Condition: Myositis Date: 2023-04-27 Interventions: anti-interferon beta therapy |
Recruiting |
Study Name: Optimizing Treatment on Idiopathic Inflammatory Myopathies Condition: Idiopathic Inflammatory Myopathies Date: 2017-03-09 Interventions: Drug: Intravenous Infusion Intravenous infusion of follow medicine at disease onset: methyprednisolone a |
Completed |
Study Name: Validation of Rehab Assessments in Myositis Patients Condition: Myositis Date: 2017-02-09 Interventions: Device: Non intervention study Test - Retest of measurements |
Not yet recruiting |
Study Name: Study of Arimoclomol in Inclusion Body Myositis (IBM) Condition: Inclusion Body Myositis Date: 2016-04-25 Interventions: Drug: Arimoclomol 2 200mg pill |
Active, not recruiting |
Study Name: An Extension Study of the Efficacy, Safety and Tolerability of BYM338 (Bimagrumab) in Patients With Sporadic Inclusion Body Myositis Who Previously Participated in the Core Study CBYM338B2203 Condition: Sporadic Inclusion Body Myositis Date: 2015-07-09 Interventions: Drug: Bimagrumab Other Name: B |
Active, not recruiting |
Study Name: Rapamycine vs Placebo for the Treatment of Inclusion Body Myositis Condition: Inclusion Body Myositis (IBM) Date: 2015-05-13 Interventions: Drug: Rapamycin Experimental: |
Recruiting |
Study Name: Belimumab in Myositis Condition: Myositis Date: 2015-01-22 Interventions: Drug: Belimumab Randomized pha |
Completed |
Study Name: Blood-flow Restricted Exercise in Inclusion Body Myositis Condition: Sporadic Inclusion Body Myositis Date: 2014-12-10 Interventions: Other: Blood-flow restricted training |